MACF1 theoretically functions as an RNA-binding protein that regulates the alternative splicing of cell cycle-associated genes in proliferative diabetic retinopathy, and will therefore be a promising treatment target for the disease [54]. Here, MACF1 is linked to proliferative diabetic retinopathy.